Founded in 2005, Northern Light Venture Capital is a venture capital investment firm headquartered in Beijing, China. The firm prefers to target early-stage opportunities of innovation and disruptive technology in China. The firm primarily focuses on TMT (technology, media, and telecom), advanced technology and healthcare sectors.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| HemaCell | 24-Feb-2022 | Early Stage VC | 000.00 | Drug Discovery | Startup | |
| 00000000 000000000 | 29-Jan-2022 | 00000 00000 | Laboratory Services (Healthcare) | Generating Revenue | ||
| 0000000000 0000 | 26-Jan-2022 | 00000 00000 | Machinery (B2B) | Generating Revenue | ||
| 000000000 000000 ( | 24-Jan-2022 | 00000 00000 | Hospitals/Inpatient Services | Generating Revenue | ||
| 00000000 000000000 | 04-Jan-2022 | 00000 00000 | General Purpose Semiconductors | Generating Revenue | 000 0000 00.0 | |
| 0000 0000000000000 | 27-Dec-2021 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 2 | |
| 0000000 00000 | 16-Nov-2021 | 00000 00000 | 0000 | Network Management Software | Generating Revenue | 0000 0000 |
| 0000000 | 15-Nov-2021 | 00000 00000 | 000.00 | Therapeutic Devices | Generating Revenue | 0000 0000 |
| Nanovision | 25-Oct-2021 | Later Stage VC | 000.00 | Diagnostic Equipment | Generating Revenue | 0000 0000 |
| TenaFe | 22-Oct-2021 | Early Stage VC | 0000 | Storage (IT) | Generating Revenue | 0000 0000 |
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Shanghai Dianrong Financial Information Services | 15-Nov-2021 | Out of Business | |
| 0000000000 | 01-Oct-2021 | 000000000 00000000 | |
| 00000 | 23-Jul-2021 | 000 | 00000 |
| 0000 00000 | 25-Jun-2021 | 000 | 00000 |
| 0000000 0000000000 | 19-Mar-2021 | 000 | 00000 |
| 000000 00000 00000 | 14-Jan-2021 | 000000000000000000 | |
| 000000 | 28-Sep-2020 | 000000000000000000 | 000 |
| 0000 0000000000 | 18-Sep-2020 | 000 | 00000 |
| Cathay Industrial Biotech | 12-Aug-2020 | IPO | 00000 |
| Langland | 27-Jul-2020 | Out of Business |
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trial| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Feng Deng | Co-Founding Managing Partner | 00 | 0 | 0 | Menlo Park, CA |
| Lixin Li | Venture Partner | Shenzhen, China | |||
| Zhi Tan Ph.D | Venture Partner | Beijing, China | |||
| Jeffrey Lee | Co-Founder, Managing Director, Partner & Chairman, Investment Committee | 0 | 0 | 0 | Menlo Park, CA |
| Yan Ke | Venture Partner & Co-Founder | Menlo Park, CA |
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Sequoia Capital China | 8 | 0 |
|
|
|
| Hillhouse Capital Group | 0 |
|
|
||
| IDG Capital | 0 |
|
|
||
| Qiming Venture Partners | 0 | 0 |
|
|
|
| Legend Capital | 0 |
|
|